Rosalind “Roz” Brewer, who served as Walgreens CEO since March 2021, stepped down from the role Aug. 31, according to the company. Ginger Graham, Walgreens’ lead independent director, will serve as interim CEO while the search for a permanent CEO is conducted.
Ms. Brewer’s departure came one month after James Kehoe stepped down as Walgreens CFO for an opportunity in the technology sector. Manmohan Mahajan, global controller and chief accounting officer, is serving as interim CFO of the company.
Walgreens has been investing heavily in its U.S. healthcare division in recent years. The company spent $5.5 billion in 2021 to acquire majority stakes in VillageMD, a primary care provider, and CareCentrix, a home healthcare company. VillageMD also inked a $9 billion deal to buy urgent care provider Summit Health in November.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.